Back to search

Pharmacodynamic and Safety Results of PEG-Hirudin in Healthy Volunteers

Data up to Jan 2025

Published1997
Citations37
References19

Total Citations Per Year

Abstract

References (19)

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

1976 • 765 citations

The Standardized Normal Ivy Bleeding Time and Its Prolongation by Aspirin

1969 • 672 citations

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

1910 • 473 citations

The development of hirudin as an antithrombotic drug

1994 • 246 citations

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

1996 • 182 citations

Pharmacological Studies on the Antithrombotic Action of Hirudin in Experimental Animals

1982 • 121 citations

A polyexponential deconvolution method. Evaluation of the “gastrointestinal bioavailability” and meanin vivo dissolution time of some ibuprofen dosage forms

1985 • 72 citations

Standardization of symbols in clinical pharmacology

1988 • 60 citations

Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures

1993 • 40 citations

Effects of Hirudin on Activated Partial Thromboplastin Time Determined with Ten Different Reagents

1993 • 39 citations

Development of a chromogenic substrate assay for the determination of hirudin in plasma

1991 • 32 citations

On the isolation of the thrombin inhibitor hirudin

1985 • 31 citations

The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits

1993 • 28 citations

The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC)

1980 • 24 citations

Prevention of Early Reocclusion after Thrombolysis of Copper Coil-induced Thrombi in the Canine Carotid Artery: Comparison of PEG-Hirudin and Unfractionated Heparin

1996 • 22 citations

Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.

1990 • 17 citations

Accelerated thrombin generation during conjunctive treatment of myocardial-infarction with t-pa and r-hirudin (cgp-39-393)

1995 • 17 citations

Alteration of pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after repeated intravenous administration in dogs

1993 • 15 citations

Effect of Recombinant Hirudin (LU 52369) on Reocclusion Rates after Thrombolysis in Rabbits

1991 • 8 citations

Cited By (0)

Loading...
Pharmacodynamic and Safety Results of PEG-Hirudin in Healthy Volunteers (1997) – Thrombosis and Haemostasis | Metascience Observatory Explorer